Forma Therapeutics formatherapeutics.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Forma Therapeutics is an oncology focused target discovery, screening, structural biology and small molecule developer. FORMA Therapeutics' scientists are passionate about discovering and developing medicines that will make a difference in oncology and other genetically driven therapeutic areas. The company's drug discovery engine drives screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis and protein-protein int...Show all

Forma Therapeutics is an oncology focused target discovery, screening, structural biology and small molecule developer. FORMA Therapeutics' scientists are passionate about discovering and developing medicines that will make a difference in oncology a...Show all

Company (Alive / Active)

Phone: 617-679-1970

Fax:

500 Arsenal Street
Suite 100
Watertown, 02472
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Forma Therapeutics $29.5M Apr 1, 2014
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Forma Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Novartis Venture FundsCorporate VentureBasel, SwitzerlandSeries B, Series A
Lilly VenturesCorporate VentureIndianapolis, Indiana, United StatesSeries B
ATEL VenturesDebt & Specialty FinanceSan Francisco, California, United StatesOther Investors
Cubist PharmaceuticalsCorporationLexington, Massachusetts, United StatesSeries B
EDBIAsset/Investment ManagementSingaporeSeries B, Series A
See all 5 investors

Competitors

Company Status Description Investors
See all 15 competitors